Analysis of defective pathways and drug repositioning in Multiple Sclerosis via machine learning approaches. - Enrique J. deAndrés-Galiana; Guillermina Bea; Juan Luis Fernández Martínez; Leo N. Saligan (Comput. Biol. Medicine, 2019)

Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19. - Enrique J. deAndrés-Galiana; Juan Luis Fernández Martínez; Óscar Álvarez-Machancoses; Guillermina Bea; Carlos M. Galmarini; Andrzej Kloczkowski (Comput. Biol. Medicine, 2022)